Drug Trial Radar · NCT05750628
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria
Last checked: Nov 19, 2026Latest source record: Jul 30, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
327
Planned (sponsor's estimate)
Start
Jan 23, 2024
Primary completion
Jun 9, 2026
Study completion Jun 23, 2026
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Mar 2, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 2 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Platform study to evaluate the efficacy and safety of anti-malarial agents in patients with uncomplicated Plasmodium falciparum malaria
Conditions
- Uncomplicated Plasmodium Falciparum Malaria
Interventions
INE963Drug
oral INE963
KAE609 (Cipargamin)Drug
oral KAE609 (Cipargamin)
SoC (Coartem)Drug
SoC (Coartem)
KLU156Drug
oral sachet KLU156 (KAF156 + lumefantrine)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A: parasite clearance time (PCT)Time frame: up to Day 7
- Part B and C: polymerase chain reaction (PCR) corrected adequate clinical and parasitological response (ACPR)Time frame: Day 29
Locations
12 sites in 6 countries. Site status is shown where the registry gives one.
Novartis Investigative Site
Banfora, Burkina Faso · Recruiting
Novartis Investigative Site
Nanoro, Burkina Faso · Recruiting
Novartis Investigative Site
Abidjan, Côte d’Ivoire · Recruiting
Novartis Investigative Site
Azaguié, Côte d’Ivoire · Recruiting
Novartis Investigative Site
Lambaréné, Gabon · Recruiting
Novartis Investigative Site
Libreville, Gabon · Recruiting
Novartis Investigative Site
Kintampo, Ghana · Recruiting
Novartis Investigative Site
Navrango, Ghana · Recruiting
Novartis Investigative Site
Kisumu, Kenya · Recruiting
Novartis Investigative Site
Ahero, Kisumu County, Kenya · Recruiting
Novartis Investigative Site
Kampala, Uganda · Recruiting
Novartis Investigative Site
Tororo, Uganda · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.